Solara-Active-Pharma (7)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE suspends trading in partly paid-up equity shares of Solara Active Pharma Sciences Limited (SOLARAPP1) effective April 02, 2026, due to … | |||||||||||||||
NSE suspends trading in partly paid-up equity shares of Solara Active Pharma Sciences Limited (SOLARAPP1) effective April 02, 2026, due to second and final call on shares.
| |||||||||||||||
NSE admits partly paid-up equity shares of Solara Active Pharma Sciences Limited (SOLARAPP1) to trading on the Capital Market segment … | |||||||||||||||
NSE admits partly paid-up equity shares of Solara Active Pharma Sciences Limited (SOLARAPP1) to trading on the Capital Market segment effective March 24, 2026, covering 71,402 shares at Rs. 7/- paid up against face value of Rs. 10/-.
| |||||||||||||||
BSE lists new securities from 10 companies issued under Employee Stock Option Plans (ESOP/ESOS), effective for trading from March 4, 2026. … | |||||||||||||||
BSE lists new securities from 10 companies issued under Employee Stock Option Plans (ESOP/ESOS), effective for trading from March 4, 2026. Companies include HDFC Bank, ICICI Bank, Wipro, and others.
| |||||||||||||||
Details of first call money received and listing approval for 19,740 partly paid-up equity shares of Solara Active Pharma Sciences Limited … | |||||||||||||||
Details of first call money received and listing approval for 19,740 partly paid-up equity shares of Solara Active Pharma Sciences Limited with paid-up value of Rs. 7/- per share.
| |||||||||||||||
Details of first call money received on partly paid-up equity shares and listing approval for 19,740 shares available for trading with … | |||||||||||||||
Details of first call money received on partly paid-up equity shares and listing approval for 19,740 shares available for trading with paid-up value of Rs. 7/-.
| |||||||||||||||
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance … | |||||||||||||||
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance regarding significant increase in trading volumes. All companies confirmed compliance with disclosure requirements and stated no price-sensitive information was withheld.
| |||||||||||||||
NSE announces listing of 3,45,923 partly paid-up equity shares of Solara Active Pharma Sciences Limited effective September 01, 2025. | |||||||||||||||
NSE announces listing of 3,45,923 partly paid-up equity shares of Solara Active Pharma Sciences Limited effective September 01, 2025.
| |||||||||||||||